Topical Delivery of Hedgehog Inhibitors: Current Status and Perspectives
Systemic treatment with hedgehog inhibitors (HHis) is available to treat basal cell carcinomas but their utility is limited by adverse effects. Topical delivery methods may reduce adverse effects, but successful topical treatment depends on sufficient skin uptake, biological response, and time in tu...
Main Authors: | Kristian Kåber Pedersen, Maria Helena Høyer-Hansen, Thomas Litman, Merete Hædersdal, Uffe Høgh Olesen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-11-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/23/22/14191 |
Similar Items
-
Recent Advances in the Clinical Targeting of Hedgehog/GLI Signaling in Cancer
by: Hao Xie, et al.
Published: (2019-04-01) -
The Efficacy of Sonidegib in Treating Locally Advanced Basal Cell Carcinoma Involving the Periocular Area
by: Alessia Villani, et al.
Published: (2023-07-01) -
Real-Life Experience with Sonidegib for Locally Advanced Basosquamous Carcinoma: A Case Series
by: Enrico Bocchino, et al.
Published: (2024-01-01) -
Sustained Suppression of Gorlin Syndrome-Associated Basal Cell Carcinomas with Vismodegib or Sonidegib: A Case Series
by: Raquel Wescott, et al.
Published: (2023-10-01) -
Sonidegib: Safety and Efficacy in Treatment of Advanced Basal Cell Carcinoma
by: Alessia Villani, et al.
Published: (2020-04-01)